Market Tracker

10/22 6:06pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

37.60
Data as of Oct 22
 +0.92 / +2.51%
Today’s Change
20.02
Today|||52-Week Range
42.50
+79.22%
Year-to-Date

Today’s Trading

Previous close36.68
Today’s open36.83
Day’s range36.49 - 38.42
Volume1,083,374
Average volume (3 months)781,241
Market cap$2.7B
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-22.49%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+26.92%
P/E ratio16.7
Price/Sales3.79
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-0.85-3.18%
WXWuxi Pharmatech Caym...-0.13-0.36%
--Cosmo Pharmaceutical...-11.95-6.38%
AVNRAvanir Pharmaceutica...-0.13-1.10%
Data as of 4:03pm ET, 10/22/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.33
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts